Autobio Diagnostics Co., Ltd. (SHA: 603658)

Autobio Diagnostics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	350.14	1,486	1,138	769.4	327.55	136.88
Short-Term Investments	2,772	2,333	3,141	3,000	3,092	611.04
Trading Asset Securities	507.62	700.57	-	7.34	85.89	120.16
Cash & Short-Term Investments	3,630	4,521	4,278	3,777	3,505	868.09
Cash Growth	-11.72%	5.66%	13.27%	7.75%	303.80%	123.25%
Accounts Receivable	1,229	1,181	1,074	1,003	958.87	636.46
Other Receivables	73.74	24.25	34.86	31.69	45.27	37.39
Receivables	1,303	1,206	1,109	1,035	1,004	673.85
Inventory	884.84	778.29	752.3	589.34	475.52	342.22
Prepaid Expenses	-	-	-	-	-	3.2
Other Current Assets	88.22	108.54	113.63	156.62	109.75	129.93
Total Current Assets	5,906	6,613	6,254	5,558	5,095	2,017
Property, Plant & Equipment	4,054	3,883	3,293	2,864	2,276	1,536
Long-Term Investments	127.96	123.31	13.76	1.72	83.42	104.27
Goodwill	164.65	164.65	164.65	164.65	164.65	171.03
Other Intangible Assets	160.85	179.03	203.27	227.85	252.2	272.37
Long-Term Deferred Tax Assets	302.13	274.61	238.73	201.76	157.83	104.26
Long-Term Deferred Charges	191.03	179.23	169.97	137.11	104.66	43.9
Other Long-Term Assets	130.57	137.55	135.59	78.07	3.21	8.06
Total Assets	11,038	11,554	10,472	9,233	8,137	4,257
Accounts Payable	812.62	726.15	1,010	355.24	438.73	180.8
Accrued Expenses	105.21	364.54	335.93	238.07	161.57	113.58
Short-Term Debt	241.33	353.28	113.84	121.39	206.63	349.12
Current Portion of Long-Term Debt	291	342	-	100.08	-	-
Current Portion of Leases	9.3	10.93	12.56	9.78	-	-
Current Income Taxes Payable	47.51	137.85	86.48	77.62	28.95	18.47
Current Unearned Revenue	132.81	148.14	135.48	125.1	95.86	37.14
Other Current Liabilities	536.79	400.25	472.27	431.28	325.19	287.93
Total Current Liabilities	2,177	2,483	2,167	1,459	1,257	987.04
Long-Term Debt	-	-	-	-	-	503.06
Long-Term Leases	24.55	24.64	16.26	26.16	-	-
Long-Term Unearned Revenue	189.22	118.98	101.77	75.68	58.29	3.99
Long-Term Deferred Tax Liabilities	279.01	258.03	273.03	269.1	236.61	128.21
Other Long-Term Liabilities	3.87	2.92	2.22	-	-	-
Total Liabilities	2,673	2,888	2,560	1,829	1,552	1,622
Common Stock	586.27	586.27	586.27	586.27	450.98	420
Additional Paid-In Capital	4,057	4,101	4,101	4,101	4,250	536.14
Retained Earnings	4,101	4,091	3,338	2,590	1,771	1,411
Treasury Stock	-459.34	-243.3	-243.3	-	-	-
Comprensive Income & Other	1.1	1.03	0.61	-0.07	5.25	190.16
Total Common Equity	8,287	8,535	7,783	7,277	6,477	2,557
Minority Interest	77.95	130.87	129.59	126.49	107.95	77.65
Shareholders' Equity	8,364	8,666	7,912	7,403	6,585	2,635
Total Liabilities & Equity	11,038	11,554	10,472	9,233	8,137	4,257
Total Debt	566.19	730.85	142.66	257.4	206.63	852.17
Net Cash (Debt)	3,064	3,790	4,136	3,520	3,299	15.92
Net Cash Growth	-13.05%	-8.36%	17.50%	6.70%	20626.03%	-94.46%
Net Cash Per Share	5.34	6.54	7.09	6.00	5.91	0.03
Filing Date Shares Outstanding	582.15	581.01	581.01	586.27	586.27	559.78
Total Common Shares Outstanding	582.15	581.01	581.01	586.27	586.27	546
Working Capital	3,730	4,130	4,087	4,099	3,838	1,030
Book Value Per Share	14.23	14.69	13.39	12.41	11.05	4.68
Tangible Book Value	7,961	8,192	7,415	6,884	6,061	2,114
Tangible Book Value Per Share	13.68	14.10	12.76	11.74	10.34	3.87
Buildings	1,364	1,152	829.25	473.02	472.47	428.49
Machinery	2,920	2,740	2,492	2,283	1,892	1,273
Construction In Progress	1,540	1,591	1,272	1,105	641.8	329.56

Source: S&P Capital IQ. Standard template. Financial Sources.